Martin Gouldstone
Directeur Général chez ONCIMMUNE HOLDINGS PLC
Fortune : 10 420 $ au 30/04/2024
Postes actifs de Martin Gouldstone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HVIVO PLC | Directeur/Membre du Conseil | 08/06/2022 | - |
| Independent Dir/Board Member | 08/06/2022 | - | |
| ONCIMMUNE HOLDINGS PLC | Directeur/Membre du Conseil | 01/08/2023 | - |
| Directeur Général | 01/08/2023 | - | |
| HVIVO PLC | Directeur/Membre du Conseil | 01/06/2022 | - |
| Independent Dir/Board Member | 01/06/2022 | - | |
| VALIRX PLC | Directeur/Membre du Conseil | 29/02/2024 | - |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Corporate Officer/Principal | - | - |
Historique de carrière de Martin Gouldstone
Anciens postes connus de Martin Gouldstone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SENSYNE HEALTH PLC | Corporate Officer/Principal | 01/03/2021 | 01/05/2022 |
Results Healthcare
 Results Healthcare Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Results Healthcare is a British company that provides advisory services. | Corporate Officer/Principal | 01/01/2017 | 01/06/2018 |
BDO UK LLP
 BDO UK LLP Miscellaneous Commercial ServicesCommercial Services BDO UK LLP provides tax, audit & assurance, advisory and business outsourcing services. The private company is based in London, UK. | Corporate Officer/Principal | 01/01/2014 | 01/01/2017 |
| BENEVOLENTAI | Corporate Officer/Principal | - | - |
| ░░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Statistiques
Internationale
| Royaume-Uni | 10 |
| Etats-Unis | 2 |
| Luxembourg | 2 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Director/Board Member | 6 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Commercial Services | 6 |
| Health Technology | 4 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SENSYNE HEALTH PLC | Commercial Services |
| HVIVO PLC | Commercial Services |
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| VALIRX PLC | Health Technology |
| BENEVOLENTAI | Health Technology |
| Entreprise privées | 6 |
|---|---|
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Retail Trade |
Owkin, Inc.
 Owkin, Inc. Packaged SoftwareTechnology Services Owkin, Inc. operates as an artificial intelligence company. It develops software which allow prediction modeling and population comparison services. The firm's products include OWKIN Socrates and OWKIN Services. The company was founded by Thomas Clozel and Gilles Wainrib in 2016 and is headquartered in Albany, NY. | Technology Services |
Orthopaedic Research UK
 Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Orthopaedic Research UK provides business support services. The non-profit company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 1989 by Ronald John Furlong. Arash Angadji has been the CEO of the company since 2008. | Commercial Services |
Results Healthcare
Results Healthcare Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Results Healthcare is a British company that provides advisory services. | Finance |
BDO UK LLP
BDO UK LLP Miscellaneous Commercial ServicesCommercial Services BDO UK LLP provides tax, audit & assurance, advisory and business outsourcing services. The private company is based in London, UK. | Commercial Services |
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
- Bourse
- Insiders
- Martin Gouldstone
- Expérience
